BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5278225)

  • 1. Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia.
    Pratt CB; Simone JV; Zee P; Aur RJ; Johnson WW
    J Pediatr; 1970 Sep; 77(3):474-83. PubMed ID: 5278225
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypofibrinogenemia and coagulation factor deficiencies with L-asparaginase treatment.
    Gralnick HR; Henderson E
    Cancer; 1971 Jun; 27(6):1313-20. PubMed ID: 5282618
    [No Abstract]   [Full Text] [Related]  

  • 3. L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease.
    Haskell CM; Canellos GP; Leventhal BG; Carbone PP; Block JB; Serpick AA; Selawry OS
    N Engl J Med; 1969 Nov; 281(19):1028-34. PubMed ID: 4898857
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation in children of the clinical, biological and electroencephalographic side effects of L-asparaginase].
    Olive D; Cartault F; Legras B; Neimann N
    Pediatrie; 1976 Apr; 31(3):259-78. PubMed ID: 1069234
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of acute leukemia with the L-asparaginase. Preliminary results based on 84 cases].
    Bernard J; Jacquillat C; Boiron M; Weil M; Bussel A; Larrieu MJ; Delobel J; Goguel A; Levy D; Tanzer J
    Presse Med (1893); 1970 Jan; 78(4):161-6. PubMed ID: 5264814
    [No Abstract]   [Full Text] [Related]  

  • 6. [L-asparaginase in the treatment of lymphoblastic leukemia in children].
    Bohlmann HG; Gallmeier WM; Göbel FJ; Stier HW
    Z Kinderheilkd; 1969; 107(2):107-14. PubMed ID: 5262681
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials of asparaginase in chemotherapy-resistant acute leukemias.
    Goudemand M; Bauters F
    Recent Results Cancer Res; 1970; 33():316-22. PubMed ID: 5292721
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia.
    Jaffe N; Traggis D; Das L; Kim BS; Won H; Hann L; Moloney WC; Dohlwitz A
    Pediatrics; 1972 Apr; 49(4):590-5. PubMed ID: 4501679
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with L-asparaginase.
    Hamilton-Fairley G; Malpas JS; Galton DA
    Recent Results Cancer Res; 1970; 33():257-62. PubMed ID: 4949164
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of acute leukemia with L-asparaginase.
    Loeb E; Hill JM; Hill NO; MacLellan A; Khan A; Alexander TR; Adachi A
    Recent Results Cancer Res; 1970; 33():204-18. PubMed ID: 5292717
    [No Abstract]   [Full Text] [Related]  

  • 11. [Apropos of certain toxic effects of L-asparaginase in human therapy].
    Oberling F; Cazenave JP; Lang JM; Kurtz D; Mayer G; Waitz R
    Sem Hop; 1971 May; 47(22):1421-5. PubMed ID: 4326093
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of acute leukemia with L-asparaginase--preliminary results on 84 cases.
    Jacquillat C; Weil M; Bussel A; Loisel JP; Rouesse T; Larrieu MJ; Boiron M; Dreyfus B; Bernard J
    Recent Results Cancer Res; 1970; 33():263-78. PubMed ID: 5292720
    [No Abstract]   [Full Text] [Related]  

  • 13. L-asparaginase (NSC-109229) plus azaserine (NSC-742) in acute lymphatic leukemia.
    Leventhal BG; Skeel RT; Yankee RA; Henderson ES
    Cancer Chemother Rep; 1970 Feb; 54(1):47-51. PubMed ID: 4945997
    [No Abstract]   [Full Text] [Related]  

  • 14. Favorable remission induction rate with twice weekly doses of L-asparaginase.
    Jaffe N; Traggis D; Das L; Frauenberger G; Hann HW; Kim BS; Bishop Y
    Cancer Res; 1973 Jan; 33(1):1-4. PubMed ID: 4565907
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse reactions of L-asparaginase.
    Cairo MS
    Am J Pediatr Hematol Oncol; 1982; 4(3):335-9. PubMed ID: 6959544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Asparaginase, 1969].
    Boiron M; Levy D
    Pathol Biol (Paris); 1969 Dec; 17(23):1129-32. PubMed ID: 4908018
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of adult leukemia with L-asparaginase (NSC-109229).
    Onuma T; Rosner F; Levy RN; Cuttner J; Moon JH; Silver RT; Blom J; Falkson G; Burningham R; Glidewell O; Holland JF
    Cancer Chemother Rep; 1971 Jun; 55(3):269-75. PubMed ID: 5315678
    [No Abstract]   [Full Text] [Related]  

  • 18. Result of a cooperative study with L-asparaginase in human leukemias. Report of the section "oncology" of the Paul-Ehrlich-Society for Chemotherapy.
    Gerhartz H; Begemann H
    Recent Results Cancer Res; 1970; 33():244-56. PubMed ID: 5292719
    [No Abstract]   [Full Text] [Related]  

  • 19. Dysmetabolic and neurological complications in leukemia patients treated with L-asparaginase.
    Storti E; Quaglino D
    Recent Results Cancer Res; 1970; 33():344-9. PubMed ID: 5292723
    [No Abstract]   [Full Text] [Related]  

  • 20. Some clinical observations on the treatment with L-asparaginase of the acute leukemias.
    Marmont AM; Damasio EE
    Recent Results Cancer Res; 1970; 33():296-315. PubMed ID: 4949165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.